Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
life sciences
nash
8
×
national blog main
texas blog main
texas top stories
national top stories
new york blog main
boston blog main
boston top stories
new york top stories
raleigh-durham blog main
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
acquisition
allergan
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
detroit blog main
detroit top stories
indiana blog main
indiana top stories
liver disease
medical devices
national
raleigh-durham top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
acelity
apax partners
biotech
botox
breast implant
breast reconstruction
What
bio
drug
roundup
acelity
antonio
known
san
approved
biogen
company
disease
ipo
liver
nash
new
news
products
week
wound
years
ace
acquired
adu
aducanumab
advanced
allogene
alnylam’s
alzheimer’s
amyloid
angst
approval
bagged
bandages
beats
bff
bids
billion
billions
biogen’s
brammer
Language
Current search:
photo
×
nash
×
@xconomy.com
5 years ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan
@xconomy.com
5 years ago
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More